secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001193125-24-283187
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics schedules 2024 annual meeting for Feb 24, 2025; sets proposal deadline Dec 30
--------------------------------------------------------------------------------

- Annual meeting set for February 24, 2025; deadline for stockholder proposals and director nominations is December 30, 2024.
- Stockholders must comply with bylaw informational requirements; notice to secretary Joel Sussman at Malvern, PA address.
- Universal proxy rule compliance requires additional notice for solicitations in support of non-company nominees by same deadline (Dec 30).
- Proposals for inclusion in proxy materials under Rule 14a-8 must be received by Dec 30 to be considered timely.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524283187/0001193125-24-283187-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524283187/d918483d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-283187

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer